Traderapple
Newbie
- Messages
- 8
- Likes
- 2
This company is MBHCF - a holding company which began in 2016 that is actively building a portfolio of profitable, earnings accretive, debt-free small to medium enterprises (SME) that are expected to have a higher-than-normal growth profile as part of a larger organization. The company's operating model leaves management of the acquired companies to operate autonomously and fully accountable to develop and grow their businesses.
MBH has announced on 19 August 2021 that it agreed to the terms for the acquisition of Vista Care Solutions Limited (Vista Care) as the latest step in its extensive acquisition drive. The completion of this acquisition is subject to regulatory approval for the proposed change of ownership from UK city councils. Upon receiving approval, Vista Care will become part of MBH's health vertical, joining Samuel Hobson House.
MBH added four new industry verticals alone in 2020 as part of a concerted acquisition drive which is continuing in 2021 with Vista care becoming the 26th company in the Group portfolio.
This has likely proven to be a catalyst, driving the share price up by almost 10% in the past week.
Analysts have price targets at up to $10 for this stock, which currently trades at about $0.30 a share. Personally, I’d seriously weigh the pros and cons before making a decision. There are some bullish signs in the company’s financials, yet there are also certain metrics that raise eyebrows, like the dilution of shares. It’s hard to say whether the company will be back in full swing after the end of the pandemic. Hopefully we’ll see MBH rise to its full potential!
MBH has announced on 19 August 2021 that it agreed to the terms for the acquisition of Vista Care Solutions Limited (Vista Care) as the latest step in its extensive acquisition drive. The completion of this acquisition is subject to regulatory approval for the proposed change of ownership from UK city councils. Upon receiving approval, Vista Care will become part of MBH's health vertical, joining Samuel Hobson House.
MBH added four new industry verticals alone in 2020 as part of a concerted acquisition drive which is continuing in 2021 with Vista care becoming the 26th company in the Group portfolio.
This has likely proven to be a catalyst, driving the share price up by almost 10% in the past week.
Analysts have price targets at up to $10 for this stock, which currently trades at about $0.30 a share. Personally, I’d seriously weigh the pros and cons before making a decision. There are some bullish signs in the company’s financials, yet there are also certain metrics that raise eyebrows, like the dilution of shares. It’s hard to say whether the company will be back in full swing after the end of the pandemic. Hopefully we’ll see MBH rise to its full potential!
